Immunotherapy Explained Part 1. Danny and I break down immunotherapy in this 3 part series. In part 1, we discuss an overview of the basic biology behind immunotherapy. Video is around 1 hour long. We talk about the various approaches…
Tag: investment
Important Upcoming Catalyst For Antares – FDA Decision Expected October 14
n a bit more deliberate than Jazz, but is coming along nicely. Antares started its royalty deals with a gel based platform, one being a royalty deal with Actavis, Inc. (NYSE: ACT) (formely Watson Pharma) for topical oxybutynin gel. Oxybutynin…
Bullish Free Articles Bullish Premium Articles Commentary Free Articles Commentary Premium Articles Free Articles Premium Articles
Edited: Is An Acquisition Of Solta Medical Imminent?
In my last article concerning Solta Medical Devices (SLTM), I remarked several times how I feel the company has good assets and the potential to grab significant market share in various segments. However, I do feel the company and its…
Video: Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
Halozyme 60 Minute, 10 Day Chart Analysis As Of Close, 9/16/13 – Sentiment = Bullish
$HALO 1132 Sept calls bought at 7.50 strike.
$HALO just had 1132 Sept calls bought at 7.50 strike, someone knows something, therefore, I bought shares, looking for Monday Potential Gap. I’ve been buying, average about $7.60 or so. CHMP decision expected in Europe,. With that many calls taken…
Correction: Weekend Update: $MNKD + $SLTM My video commentary on what is really going on with Mannkind and Solta (Public Video)
Weekend Update: $MNKD + $SLTM. My video commentary on what is really going on with Mannkind and Solta
Voce Capital Pushes For Acquisition Of Solta Medical, Activist Investor David Callan Joins In
Merger and acquisition speculation is one of the most interesting and exciting elements of the stock market. Sometimes both activist institutions and private investors can leverage deals or stop deals from happening depending on how many shares they control in…
Scott’s Mid-Week Market Commentary For Week Aug 6 – 9/2013
Scott’s Mid-Week Market Commentary For Week Aug 6 – 9/2013. $ONTX $INSM $AEGR $AUXL plus commentary on Market conditions and current chatter concerning the latest “terrorist threats,” and more!
Trius Acquired Last Week, Tetraphase Could Be Next
Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer Pharmaceuticals Inc. (OPTR) for as much as $1.62 billion. Cubist…
Biodel Video Chart Analysis
My Biodel Chart Analysis Video – StockMatusow.com ‘s price target opinion for this catalyst run-up trade is around $6
